Lynx Dx has commercially launched MyProstateScore 2.0 (MPS2), a urine test kit for prostate cancer intended for at-home ...

Active surveillance is widely used for men with low-risk prostate cancer, but existing tools have important limitations and monitoring relies on repeated biopsies that burden patients and practices.

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade ...

An experimental urine test can detect aggressive prostate cancers in men on active surveillance, potentially sparing them from repeated biopsies, researchers reported on Friday. The MPS2-AS test is ...

Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. "This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and ...